1. INTRODUCTION
1.1. Market Overview
1.2. Market Definition
1.3. Scope of the Study
1.4. Market Segmentation
1.5. Currency
1.6. Assumptions
1.7. Base and Forecast Years Timeline
1.8. Key benefits to the stakeholder
2. RESEARCH METHODOLOGY
2.1. Research Design
2.2. Research Process
3. EXECUTIVE SUMMARY
3.1. Key Findings
3.2. Analyst View
4. MARKET DYNAMICS
4.1. Market Drivers
4.2. Market Restraints
4.3. Porter’s Five Forces Analysis
4.3.1. Bargaining Power of Suppliers
4.3.2. Bargaining Power of Buyers
4.3.3. Threat of New Entrants
4.3.4. Threat of Substitutes
4.3.5. Competitive Rivalry in the Industry
4.4. Industry Value Chain Analysis
4.5. Analyst View
5. GENOMIC MEDICINE MARKET BY APPLICATION
5.1. Introduction
5.2. Oncology
5.2.1. Market opportunities and trends
5.2.2. Growth prospects
5.2.3. Geographic lucrativeness
5.3. Pharmacogenomics
5.3.1. Market opportunities and trends
5.3.2. Growth prospects
5.3.3. Geographic lucrativeness
5.4. Rare and Undiagnosed Diseases
5.4.1. Market opportunities and trends
5.4.2. Growth prospects
5.4.3. Geographic lucrativeness
5.5. Infectious Diseases
5.5.1. Market opportunities and trends
5.5.2. Growth prospects
5.5.3. Geographic lucrativeness
5.6. Cardiovascular Diseases
5.6.1. Market opportunities and trends
5.6.2. Growth prospects
5.6.3. Geographic lucrativeness
5.7. Neurological Disorders
5.7.1. Market opportunities and trends
5.7.2. Growth prospects
5.7.3. Geographic lucrativeness
5.8. Others
5.8.1. Market opportunities and trends
5.8.2. Growth prospects
5.8.3. Geographic lucrativeness
6. GENOMIC MEDICINE MARKET BY PRODUCTS AND SERVICES
6.1. Introduction
6.2. Instruments and Equipment
6.2.1. Market opportunities and trends
6.2.2. Growth prospects
6.2.3. Geographic lucrativeness
6.3. Consumables
6.3.1. Market opportunities and trends
6.3.2. Growth prospects
6.3.3. Geographic lucrativeness
6.4. Services (Genomic Testing, Data Analysis, Interpretation, Genetic Counselling)
6.4.1. Market opportunities and trends
6.4.2. Growth prospects
6.4.3. Geographic lucrativeness
7. GENOMIC MEDICINE MARKET BY TECHNOLOGY
7.1. Introduction
7.2. Next-Generation Sequencing (NGS)
7.2.1. Market opportunities and trends
7.2.2. Growth prospects
7.2.3. Geographic lucrativeness
7.3. Polymerase Chain Reaction (PCR)
7.3.1. Market opportunities and trends
7.3.2. Growth prospects
7.3.3. Geographic lucrativeness
7.4. Microarray
7.4.1. Market opportunities and trends
7.4.2. Growth prospects
7.4.3. Geographic lucrativeness
7.5. Sanger Sequencing
7.5.1. Market opportunities and trends
7.5.2. Growth prospects
7.5.3. Geographic lucrativeness
7.6. Others
7.6.1. Market opportunities and trends
7.6.2. Growth prospects
7.6.3. Geographic lucrativeness
8. GENOMIC MEDICINE MARKET BY END-USER
8.1. Introduction
8.2. Hospitals and Clinics
8.2.1. Market opportunities and trends
8.2.2. Growth prospects
8.2.3. Geographic lucrativeness
8.3. Diagnostic Laboratories
8.3.1. Market opportunities and trends
8.3.2. Growth prospects
8.3.3. Geographic lucrativeness
8.4. Research Institutes
8.4.1. Market opportunities and trends
8.4.2. Growth prospects
8.4.3. Geographic lucrativeness
8.5. Pharmaceutical and Biotechnology Companies
8.5.1. Market opportunities and trends
8.5.2. Growth prospects
8.5.3. Geographic lucrativeness
9. GENOMIC MEDICINE MARKET BY GEOGRAPHY
9.1. Introduction
9.2. North America
9.2.1. By Application
9.2.2. By Products And Services
9.2.3. By Technology
9.2.4. By End-user
9.2.5. By Country
9.2.5.1. United States
9.2.5.1.1. Market Trends and Opportunities
9.2.5.1.2. Growth Prospects
9.2.5.2. Canada
9.2.5.2.1. Market Trends and Opportunities
9.2.5.2.2. Growth Prospects
9.2.5.3. Mexico
9.2.5.3.1. Market Trends and Opportunities
9.2.5.3.2. Growth Prospects
9.3. South America
9.3.1. By Application
9.3.2. By Products And Services
9.3.3. By Technology
9.3.4. By End-user
9.3.5. By Country
9.3.5.1. Brazil
9.3.5.1.1. Market Trends and Opportunities
9.3.5.1.2. Growth Prospects
9.3.5.2. Argentina
9.3.5.2.1. Market Trends and Opportunities
9.3.5.2.2. Growth Prospects
9.3.5.3. Others
9.3.5.3.1. Market Trends and Opportunities
9.3.5.3.2. Growth Prospects
9.4. Europe
9.4.1. By Application
9.4.2. By Products And Services
9.4.3. By Technology
9.4.4. By End-user
9.4.5. By Country
9.4.5.1. Germany
9.4.5.1.1. Market Trends and Opportunities
9.4.5.1.2. Growth Prospects
9.4.5.2. France
9.4.5.2.1. Market Trends and Opportunities
9.4.5.2.2. Growth Prospects
9.4.5.3. UK
9.4.5.3.1. Market Trends and Opportunities
9.4.5.3.2. Growth Prospects
9.4.5.4. Spain
9.4.5.4.1. Market Trends and Opportunities
9.4.5.4.2. Growth Prospects
9.4.5.5. Italy
9.4.5.5.1. Market Trends and Opportunities
9.4.5.5.2. Growth Prospects
9.4.5.6. Others
9.4.5.6.1. Market Trends and Opportunities
9.4.5.6.2. Growth Prospects
9.5. Middle East and Africa
9.5.1. By Application
9.5.2. By Products And Services
9.5.3. By Technology
9.5.4. By End-user
9.5.5. By Country
9.5.5.1. Saudi Arabia
9.5.5.1.1. Market Trends and Opportunities
9.5.5.1.2. Growth Prospects
9.5.5.2. UAE
9.5.5.2.1. Market Trends and Opportunities
9.5.5.2.2. Growth Prospects
9.5.5.3. Others
9.5.5.3.1. Market Trends and Opportunities
9.5.5.3.2. Growth Prospects
9.6. Asia Pacific
9.6.1. By Application
9.6.2. By Products And Services
9.6.3. By Technology
9.6.4. By End-user
9.6.5. By Country
9.6.5.1. China
9.6.5.1.1. Market Trends and Opportunities
9.6.5.1.2. Growth Prospects
9.6.5.2. Japan
9.6.5.2.1. Market Trends and Opportunities
9.6.5.2.2. Growth Prospects
9.6.5.3. India
9.6.5.3.1. Market Trends and Opportunities
9.6.5.3.2. Growth Prospects
9.6.5.4. South Korea
9.6.5.4.1. Market Trends and Opportunities
9.6.5.4.2. Growth Prospects
9.6.5.5. Indonesia
9.6.5.5.1. Market Trends and Opportunities
9.6.5.5.2. Growth Prospects
9.6.5.6. Taiwan
9.6.5.6.1. Market Trends and Opportunities
9.6.5.6.2. Growth Prospects
9.6.5.7. Others
9.6.5.7.1. Market Trends and Opportunities
9.6.5.7.2. Growth Prospects
10. COMPETITIVE ENVIRONMENT AND ANALYSIS
10.1. Major Players and Strategy Analysis
10.2. Market Share Analysis
10.3. Mergers, Acquisition, Agreements, and Collaborations
10.4. Competitive Dashboard
11. COMPANY PROFILES
11.1. Illumina, Inc.
11.2. Thermo Fisher Scientific, Inc.
11.3. F. Hoffmann-La Roche Ltd.
11.4. QIAGEN N.V.
11.5. Pacific Biosciences of California, Inc.
11.6. BGI Genomics
11.7. Oxford Nanopore Technologies Ltd.
11.8. PerkinElmer, Inc.
11.9. Bio-Rad Laboratories, Inc.
11.10. Agilent Technologies, Inc.